Andre Larente
-
André Larente on DIAGNOS’ Partnership with EssilorLuxottica to Expand AI Retinal Analysis and Offers Updates on Regulatory Approvals
September 09, 2024 — In a recent interview with InvestorNews host Pat Bolland, André Larente, President, CEO, and Director…
-
InvestorTalk Alert: Andre Larente from Diagnos Inc. to host on Thursday, September 5, 2024
InvestorNews is pleased to announce an upcoming InvestorTalk scheduled for tomorrow, Thursday, September 5th, at 9 AM EST,…
-
André Larente from DIAGNOS on Transforming Optometry and Expanding AI Capabilities
April 29, 2024 — In a recent interview with InvestorNews host Tracy Weslosky, André Larente, President, CEO, and…
-
Andre Larente from DIAGNOS to Host InvestorTalk (04.24.2024)
InvestorNews is hosting an InvestorTalk this morning with André Larente, CEO, President, and Director from DIAGNOS Inc. (TSXV:…
-
Andre Larente from DIAGNOS on Deal with World’s Largest Eyecare Retailer EssilorLuxottica
InvestorNews host Tracy Weslosky recently conducted an insightful interview with André Larente, President and Director of DIAGNOS Inc.…
-
André Larente provides an update on the ‘exponential growth’ of the Diagnos AI-based telemedicine platform
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente, President of Diagnos Inc. (TSXV: ADK |…
-
Diagnos’ André Larente on Entering the DACH and Central European Healthcare Market
In a recent InvestorIntel interview, Tracy Weslosky spoke with André Larente President of Diagnos Inc. (TSXV: ADK |…
-
Diagnos’ Andre Larente on the benefits of using AI for the early detection of critical health issues
“Our (AI) technology works, its in production (CARA). We are fully funded….the markets we are going after are…
